Early heart drug safety test halted
NCT ID NCT02479204
Summary
This early-stage study aimed to check the safety of a new experimental drug, ACT-334441, when taken with two common heart medications (diltiazem and atenolol). It involved a small group of healthy volunteers to see if the drug combination affected heart rate, blood pressure, or caused other side effects. The study was terminated early, and its main goal was to gather safety information, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BIOTRIAL
Rennes, CS 34246, France
Conditions
Explore the condition pages connected to this study.